The U.S. medical mask market size to cross USD 586 million by 2025, growing at a CAGR of over 23% during the forecast period. The U.S. medical mask market is growing at a CAGR of over 18% by volume during the period 2020–2025. The U.S. accounted for a volume share of over 88% of the North American market. Better accessibility to medical services and improved healthcare coverage spend are the major factors responsible for high market share. However, the increase in the prevalence of acute and chronic diseases, including heart diseases, diabetes, cancer and the outbreak of pandemic such as COVID-19, which has led to the increased usage of disposable medical face masks, aggressive expansion plans by vendors to penetrate the U.S. market are likely to fuel the growth of the market in the country. Moreover, favorable government recommendations for wearing protective equipment to avoid any type of infection in healthcare settings are another factor driving the market growth in the country.
- The surgical mask market is expected to reach over 6 billion units by 2025. The growth is due to increased recommendations from world healthcare bodies to use personal protective equipment to curb the spread of coronavirus and other diseases.
- In terms of volume, the hospital segment is likely to observe an incremental growth of close to 3 billion units by 2025. This growth is on account of the high uptake of protective gear for HCPs in several private and public hospitals.
- The south region is projected to grow at the CAGR of close to 25% during the period 2019–2025 because of better patient management, an increase in invasive surgical procedures, and high disease awareness.
U.S. MEDICAL MASK MARKET SEGMENTATION
This research report includes a detailed segmentation by
INSIGHTS BY PRODUCTS
Surgical masks are considered as the primary standard of protection and are used by medical professionals in low, medium, or high level medical and experimental laboratory procedures. The segment has witnessed a steep increase since the spread of novel coronavirus across the globe. The medical masks for coronavirus can prevent the spread of the virus as they act as a barrier and can easily contain liquid particles (respiratory droplets and aerosols). With the FDA recognizing the need for protective gear and equipment during the COVID-19 outbreak, healthcare organizations offer adequate guidelines to manufacturers to maintain seamless manufacturing and supply and avoid shortage of personal protective equipment across the region. This, in turn, will further contribute to the growth of the segment.
As the U.S. region has become one of the most severely affected countries in the COVID-19 pandemic, there has been a surge in demand for respiratory masks, particularly for HCPs that are working in healthcare facilities to treat COVID-19 patients. Respirator ones offer more protection than surgical ones because they can filter out both large as well as small particles. Therefore, the CDC recommends the use of these as personal protective equipment for frontline healthcare workers and strategizes for optimizing the supply of the respirator ones for seamless manufacturing and supply to combat the pandemic.
INSIGHTS BY END-USERS
In 2019, the hospital end-user segment accounted for over 57% volume share of the U.S. medical mask market. The market is growing at a healthy rate, which is likely to grow during the forecast period due to the high adoption of the latest generation treatment practices with standard hygiene and safety measures. As the majority of patients with a high risk of diseases prefer visiting hospitals for treatment due to advanced infrastructure care facilities, the hospital segment is expected to grow during the forecast period.
The clinic end-users segment constituted a 12% volume share of the U.S. medical mask market in 2019. The rising prevalence of several acute and chronic diseases and associated surgeries, infections, and injuries are expected to drive the clinic's medical face mask market in North America. HCPs in clinics use these protective devices for effective barrier protection for themselves and patients while treating patients with diseases. The increased importance of mobile health clinics in the region is also driving the rising uptake of medical face masks as PPE during the forecast period.
The diagnostic laboratories end-users segment is expected to grow at a CAGR of over 16% during the period 2019¬2025. The segment is growing due to the widespread use of medical face masks in laboratory settings. Examination masks are used in these settings by research professionals. In the recent COVID-19 pandemic, diagnostic laboratories are on the frontlines of the battle against the virus, providing specimen collection, coordinating supplies, and offering to test. Therefore, surgical and respirator masks are a crucial component of personal protection gears, which are used in combination with gowns, face shields, eye protection glasses, and medical gloves.
INSIGHTS BY GEOGRAPHY
The southern region is expected to reach revenue of over $1.39 billion by 2025. Based on the volume shipment, the South region holds the largest U.S. medical mask market share. The increasing awareness of using disposable face masks as essential safety equipment associated with treatment procedures of several diseases, coupled with improved healthcare infrastructure, with favorable guidelines and the availability of technologically advanced healthcare devices is driving the growth of the U.S. medical face mask market in the region.
The region is witnessing a surge in the number of COVID-19 cases. As of July 12, 2020, Florida recorded around 15,300 new cases. Texas also recorded around 265,000 confirmed COVID-19 cases on July 12, 2020. Therefore, with the growing number of cases, health officials in several South states are mandatorily recommending wearing protective gear to arrest the spread of the virus. Thus, the region will need a greater number of medical and N95 face masks for both HCPs and the general public, which is contributing to the higher growth rate of the market.
INSIGHTS BY VENDORS
The U.S. medical mask market share is highly competitive and dynamic, with the presence of many global, regional, and local vendors offering a diverse range of surgical and respirator medical face masks to end-users. With the outbreak of COVID-19, the number of companies manufacturing them has increased exponentially. 3M, Honeywell, Kimberly-Clark, Owens & Minor, and Prestige Ameritech are the largest manufacturer of medical masks and have demonstrated consistent growth over the last few years. Moderate to the high growth of major players will continue to boost market growth. Moreover, both established and emerging players are developing or commercializing the manufacturing with advanced features such as fog-free features, 3-D designed masks for an accurate fit to pursue sustainability strategies.
The U.S. medical mask market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Product
- Diagnostic Laboratories